You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biosimilar

Showing 1 - 25 of 698
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

Not yet recruiting
  • Multiple Myeloma
  • +3 more
  • (no location specified)
Oct 30, 2023

Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Nov 15, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 4, 2023

Infertility Trial in Xi'an (Biosimilar cetrorelix acetate, Reference cetrorelix acetate)

Not yet recruiting
  • Infertility
  • Biosimilar cetrorelix acetate
  • Reference cetrorelix acetate
  • Xi'an, None Selected, China
    He Cai
Sep 7, 2023

Psoriasis Trial in Lahore (Remsima)

Completed
  • Psoriasis
  • Lahore, Punjab, Pakistan
    Ghurki Hospital
Sep 12, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

Hidradenitis Suppurativa Trial in Lahore (Infliximab biosimilar)

Active, not recruiting
  • Hidradenitis Suppurativa
  • Infliximab biosimilar
  • Lahore, Punjab, Pakistan
    Services Institute of Medical Sciences
Dec 22, 2022

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

Not yet recruiting
  • Melanoma
  • (no location specified)
Nov 22, 2023

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +10 more
  • Bevacizumab
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2022

Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular

Not yet recruiting
  • Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • +2 more
  • Biopsy
  • +9 more
  • (no location specified)
Jun 1, 2023

Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

Active, not recruiting
  • Recurrent Brain Neoplasm
  • Bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder Trial

Not yet recruiting
  • Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
  • Polymorphic Post-Transplant Lymphoproliferative Disorder
  • Biopsy
  • +5 more
  • New Brunswick, New Jersey
  • +2 more
Mar 23, 2023

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +2 more
  • Los Angeles, California
  • +17 more
Jan 27, 2023

Medicine Called Infliximab[Infliximab Biosimilar 3] in People

Not yet recruiting
  • Arthritis, Rheumatoid
  • +3 more
    • (no location specified)
    Mar 31, 2023

    Retention ofAdalimumab Biosimilar in IBD Real Life Setting

    Not yet recruiting
    • Inflammatory Bowel Disease
    • Hyrimoz
    • (no location specified)
    Nov 21, 2022

    Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

    Active, not recruiting
    • Prolymphocytic Leukemia
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

    Recruiting
    • Resectable Hepatocellular Carcinoma
    • +4 more
    • Atezolizumab
    • +2 more
    • Houston, Texas
    • +1 more
    Oct 12, 2022

    Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

    Active, not recruiting
    • Ann Arbor Stage I Grade 1 Follicular Lymphoma
    • +3 more
    • Clinical Observation
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)

    Recruiting
    • Peritoneal Malignant Mesothelioma
    • Atezolizumab
    • +8 more
    • Phoenix, Arizona
    • +25 more
    Feb 2, 2023

    Diabetes Trial (Insulin Degludec and Insulin Aspart)

    Not yet recruiting
    • Diabetes
    • Insulin Degludec and Insulin Aspart
    • (no location specified)
    Apr 4, 2023

    HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

    Not yet recruiting
    • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
    • PERT-IJS plus trastuzumab, carboplatin and docetaxel
    • Perjeta plus trastuzumab, carboplatin and docetaxel
    • (no location specified)
    Sep 21, 2023

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

    Not yet recruiting
    • Metastatic Colon Adenocarcinoma
    • +5 more
    • Trastuzumab
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Jan 31, 2023